AIMDW
Ainos, Inc.
Set alert
- YTD
- -47.67%
- 1 year
- -47.67%
- Open
- 0.17
- Prev close
- 0.0579
- Mkt cap
- 1.59M
- Vol
- 186
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0305
- High
- 0.0579
- Forward P/E
- 0.00
- Beta
- 1.41
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.02
- EPS (TTM)
- 0.00
- Beta
- 1.41
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 40.63K
- Revenue growth
- 0.00%
- Free cash flow
- 621.86K
- Total cash
- 5.16M
- Total debt
- 12.27M
- Return on equity
- -70.60%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
About Ainos, Inc.
Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- ainos.com
News
- Ainos Announces AI Nose Platform Hits Over 3B Chemical Data Points
- Ainos, Inc. (NASDAQ:AIMDW) Sees Significant Drop in Short Interest
- Ainos Completes Required Data Delivery And Technology Transfer Under Its VELDONA License Deal For $600K Initial License Payment
- Ainos Receives Three New Japanese Patents For Its AI Nose Technologies
- Ainos’ AI Nose Platform Surpasses 878M Real-World Smell And Chemical Data Points, Primarily Generated From Semiconductor Manufacturing And Real-World Operating Environments
- Ainos Notes Review Of Its One-Year, AI-Analyzed Breath Pattern Study Focusing On Chronic Obstructive Pulmonary Disease
- Ainos, Inc. (NASDAQ:AIMDW) Sees Significant Decrease in Short Interest
- Ainos Activates Phased Industrial Deployment Roadmap To Install Up To 20K AI Nose Units
Your note
Sign in to keep a note on AIMDW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| CVI Holdings, LLC | 10.58% | 82,500 | 2.41K | Jun 29, 2024 |
| Heights Capital Management, Inc | 10.58% | 82,500 | 2.41K | Sep 29, 2024 |
| Citadel Advisors Llc | 5.99% | 46,717 | 1.36K | Sep 29, 2024 |
| Boothbay Fund Management, LLC | 3.21% | 25,000 | 730 | Sep 29, 2024 |
| Warberg Asset Management LLC | 2.41% | 18,800 | 548 | Sep 29, 2024 |
| Flow Traders U.S. LLC | 1.37% | 10,675 | 311 | Sep 29, 2024 |